BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Yellow Grant//EU grant deadlines//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:horizon-miss-2027-02-cancer-03-20270916T000000Z@deadlines.grant-grants.com
DTSTAMP:20261103T184627Z
DTSTART:20270916T000000Z
DTEND:20270916T000000Z
SUMMARY:Deadline: Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
DESCRIPTION:This is a Research and Innovation Action under Horizon Europe. The budget is €24 million for about 3 grants of €7 million to €9 million each. It is paid as a lump sum\, so you report results instead of costs. Submission opens on 10 February 2027. Deadline: 16 September 2027.\nhttps://deadlines.grant-grants.com/calls/horizon-miss-2027-02-cancer-03/
URL:https://deadlines.grant-grants.com/calls/horizon-miss-2027-02-cancer-03/
BEGIN:VALARM
TRIGGER:-P7D
ACTION:DISPLAY
DESCRIPTION:EU call deadline in 7 days
END:VALARM
END:VEVENT
END:VCALENDAR